Daré Bioscience, Inc.

NasdaqCM:DARE Stock Report

Market Cap: US$28.1m

Daré Bioscience Management

Management criteria checks 3/4

Daré Bioscience's CEO is Sabrina Johnson, appointed in May 2015, has a tenure of 9.67 years. total yearly compensation is $1.22M, comprised of 40.5% salary and 59.5% bonuses, including company stock and options. directly owns 0.92% of the company’s shares, worth $258.96K. The average tenure of the management team and the board of directors is 8.1 years and 7.5 years respectively.

Key information

Sabrina Johnson

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage40.5%
CEO tenure9.7yrs
CEO ownership0.9%
Management average tenure8.1yrs
Board average tenure7.5yrs

Recent management updates

Recent updates

We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

Nov 07
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Jul 21
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Mar 12
Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms

Oct 17

Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive

Oct 10

Dare Bioscience reports positive progress for cream for female sexual arousal disorder

Aug 29

Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy

Jun 30

Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Apr 02
Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Diving Back Into Daré Bioscience Again

Jan 07

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Nov 26
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study

Apr 26

Diving Into Daré Bioscience

Jan 31

Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dec 22
Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dare Bioscience EPS misses by $0.06

Nov 12

CEO Compensation Analysis

How has Sabrina Johnson's remuneration changed compared to Daré Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$4m

Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$29m

Dec 31 2023US$1mUS$495k

-US$30m

Sep 30 2023n/an/a

-US$41m

Jun 30 2023n/an/a

-US$40m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$2mUS$466k

-US$31m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$40m

Dec 31 2021US$2mUS$405k

-US$39m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$33m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$835kUS$368k

-US$27m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$19m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$629kUS$335k

-US$15m

Sep 30 2019n/an/a

-US$14m

Jun 30 2019n/an/a

-US$13m

Mar 31 2019n/an/a

-US$12m

Dec 31 2018US$618kUS$325k

-US$17m

Compensation vs Market: Sabrina's total compensation ($USD1.22M) is above average for companies of similar size in the US market ($USD640.16K).

Compensation vs Earnings: Sabrina's compensation has been consistent with company performance over the past year.

CEO

Sabrina Johnson (57 yo)

9.7yrs

Tenure

US$1,222,108

Compensation

Ms. Sabrina Martucci Johnson serves as Director at BIOCOM, Inc. since February 2021 and serves as its Chairman since January 2025. Ms. Johnson Founded Daré Bioscience since 2015 and serves as its Chief Exe...

Leadership Team

NamePositionTenureCompensationOwnership
Sabrina Johnson
CEO, President9.7yrsUS$1.22m0.92%
$ 259.0k
Mark Walters
Vice President of Operations10yrsno datano data
MarDee Haring-Layton
Chief Accounting Officer2.8yrsno datano data
David Friend
Chief Scientific Officer6.6yrsno datano data

8.1yrs

Average Tenure

57yo

Average Age

Experienced Management: DARE's management team is seasoned and experienced (8.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sabrina Johnson
CEO, President7.5yrsUS$1.22m0.92%
$ 259.0k
William Rastetter
Independent Chairman of the Board11yrsUS$113.89k0.0099%
$ 2.8k
Robert S. Langer
Member of Scientific Advisory Board5.8yrsno datano data
Susan Kelley
Independent Director10.3yrsUS$78.89k0%
$ 0
Robin Steele
Independent Director7.5yrsUS$86.39k0.24%
$ 66.3k
Jessica Grossman
Independent Director6.8yrsUS$83.89k0%
$ 0
Gregory Matz
Independent Director6.3yrsUS$93.89k0.00048%
$ 134.9

7.5yrs

Average Tenure

68yo

Average Age

Experienced Board: DARE's board of directors are considered experienced (7.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 23:49
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Daré Bioscience, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Brian Kemp DolliverBrookline Capital Markets
Douglas TsaoH.C. Wainwright & Co.